HUM · Humana Inc
Price
Snapshot
50 fields · last close| Market Cap | $48.82B |
| P/E | 37.87 |
| Float | 119.8M |
| Beta | 0.68 |
| Volatility | 17.0% |
| Exchange | NYSE |
| Sector | Health Care |
| Cap tier | Large cap |
| Macro sensitivity | Moderate |
| Clavix score | 72 |
| Price | 402.98 |
| Change | −0.87% |
| Prev Close | 406.52 |
| Open | 401.96 |
| Day Low | 397.87 |
| Day High | 413.50 |
| Avg Vol | 1 |
| Avg $ Vol | $432.6M |
| 52W High | 428.88 |
| 52W Low | 163.11 |
| 52W Pos | 90.3% |
| From High | −6.04% |
| From Low | +147.06% |
| Max DD 1Y | −47.54% |
| Spread | 0.10% |
| Liquidity | Normal |
| SMA 20 | +4.11% |
| SMA 50 | +3.90% |
| SMA 200 | +44.50% |
| RSI (14) | 63.3 |
| Vol 30D | 35.9% |
| Vol 90D | 41.5% |
| 1Y Range | 163–429 |
| Daily bars | 506 |
| Perf Week | +3.54% |
| Perf Month | +11.74% |
| Perf Quarter | +16.21% |
| Perf Half Y | +124.91% |
| Perf Year | +30.30% |
| Perf YTD | +52.37% |
| Prev Day | −0.87% |
| Clavix | B |
| Debt / Eq | 0.70 |
| Curr Ratio | 0.01 |
| Int Cover | 3.4× |
| FCF Margin | 2.6% |
| Rev Growth | +26.2% |
| Profit | Profitable |
| Leverage | Moderate |
| Sector rank | 29 / 47 |
What HUM does
Humana Inc. provides medical and specialty insurance products in the United States.
It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers.
Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions.
The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974.
Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Clavix risk grade
regraded every trading dayHUM grades B, 72 of 100. Steadiest on Sector Resilience (70), most exposed on Price Stability (54, mixed). 2 of the 4 weighted dimensions sit above the Health Care median. Ranks 29 of 47 in Health Care by Clavix score.
How rough the ride is
| HUM | Health Care median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 0.68 | 0.81 |
| Volatilityannualized | 17.0% | 20.4% |
| Max drawdown, past yearworst peak-to-trough fall | −47.5% | — |
| Typical daily movemedian absolute daily change | 1.43% | — |
| Days beyond ±3%of the last 252 sessions | 5823% | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| HUM | Health Care median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 0.68 | 0.81 |
| Macro sensitivityrate, dollar and credit exposure bucket | Moderate | Moderate55% of 47 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Health Care names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| HUM | |
|---|---|
| 1 week | +3.5% |
| 1 month | +11.7% |
| Year to date | +52.4% |
| 1 year | +30.3% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| HUM | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 30since 29 Jul |
| Average score0 most bearish, 100 most bullish | 60 |
| Bullish · bearisharticles above 60 · below 40 | 21 · 5 |
| Directionarticles whose tone is improving vs worsening | 21 ↑ 5 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 47 Health Care names Clavix covers; the tick is the sector median.
Growth
| HUM | |
|---|---|
| Revenue growthyear over year | +26.2% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Health Care median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Against Health Care
47 companies| Metric | HUM | Sector spread | Median |
|---|---|---|---|
| Beta | 0.68 | 0.81 | |
| Volatility | 17.0% | 20.4% | |
| P/E | 37.87 | 26.14 | |
| Debt / equity | 0.70 | 0.71 | |
| Current ratio | 0.01 | 1.58 | |
| FCF margin | 2.6% | 8.6% | |
| Interest coverage | 3.4× | 6.3× |
Recent news
most recent scored articles · the chip is the article’s score · click to openHumana's Board of Directors declared a quarterly cash dividend of $0.885 per share, payable on November 27, 2026 to shareholders of record as of October 30, 2026.
Villages Health, a Central Florida healthcare provider owned by Humana, agreed to a $542 million settlement after the Department of Justice found the company created fake diagnosis codes to overbill Medicare Advantage from 2020 to 2024.
A federal judge denied Mylan and Lannett's request to dismiss claims in Humana's lawsuit alleging the two companies conspired to fix generic drug prices, calling the motion premature ahead of a bellwether trial (a representative test case used in large multidistrict litigation). The judge also noted that other parties in the broader case did not join the motion.
The article is a brief opinion piece recommending investors hold onto Humana (HUM) stock, citing Medicare Advantage growth, CenterWell expansion, and strong cash generation as positives, while noting rising costs and debt as concerns. The body is too short to contain specific numbers, dates, or concrete developments.
An analyst recommends holding onto Humana stock, citing growth in Medicare Advantage health plans, expansion of CenterWell primary care clinics, and strong cash generation as positives, while flagging rising costs and debt as concerns.
Nearest peers by size
Health Care| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| MDLN | Medline Inc | B | $48.11B | 67.50 | 0.78 | Compare |
| BDX | Becton Dickinson and Co | A- | $51.11B | 54.01 | 0.24 | Compare |
| EW | Edwards Lifesciences Corp | A- | $51.75B | 51.53 | 0.84 | Compare |
| IDXX | IDEXX Laboratories Inc | B+ | $41.70B | 36.69 | 1.57 | Compare |
| CAH | Cardinal Health Inc | A- | $57.82B | 33.59 | 0.54 | Compare |
| COR | Cencora Inc | B+ | $64.35B | 24.52 | 0.59 | Compare |
| BSX | Boston Scientific Corp | B | $68.04B | 18.98 | 0.59 | Compare |
| VEEV | Veeva Systems Inc | B- | $34.18B | 45.52 | 0.91 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. Three months free on iPhone.